Simone Bini retweeted
Lipid lowering drugs in special population: focus on kidney disease. @Arca_Lab_
@Tramontano_D @_SimoneBini_
pubmed.ncbi.nlm.nih.gov/4010…
Simone Bini retweeted
atherosclerosis-journal.com/…
Our latest effort is the result of an international collaboration focused on understanding the consequences of hypertriglyceridemia. #triglycerides #kidneydisease
@ATHjournal @_SimoneBini_
Simone Bini retweeted
ANGPTL3 binds to PCSK9 to coordinately regulate intracellular lipid homeostasis. biorxiv.org/cgi/content/shor… #biorxiv_cellbio
Simone Bini retweeted
Grateful to have had the opportunity to see @amitvkhera at La Sapienza University of Rome, sharing insights on gene editing therapies for cardiovascular disease. It was an inspiring discussion. @Arca_Lab_ @Lauraderasmo @_SimoneBini_
Simone Bini retweeted
Thanks to @STARProtocols for accepting our protocol for the staining and quantification of LDLs using oil red O.
doi.org/10.1016/j.xpro.2024.…
@society_eas
@SISA_Academy
Simone Bini retweeted
Thanks to @JACCJournals for the publication
shorturl.at/W13lF
We are proud to share with you our latest achievement: another step forward in understanding the liver consequences of hypocholesterolemic syndrome.
@society_eas @SISA_Academy @SapienzaRoma @RicercaSapienza
Simone Bini retweeted
It was a fantastic Adventure! A meeting that represents an incredible training and networking opportunity! @EASCongress @Arca_Lab_
Simone Bini retweeted
📢We are excited to announce that registration for the #EASCongress2024 is open! Get the chance to engage with leading experts, explore the latest advancements in the #atherosclerosis field & network with professionals from around the globe.
Register now: bit.ly/3RmEzu9
Simone Bini retweeted
LabArca at regional SISA congress. Brilliant opening by @AL_Catapano. Interesting topics on novel treatments and adherence also today. Thank to the president (@daniele_pastori) for the invitation. – at Rome, Lazio
Simone Bini retweeted
A big achievement for a great collaborative team! A new important information on ANGPTL3 targeting ahajournals.org/doi/10.1161/…
@Arca_Lab_ @_SimoneBini_ @RicercaSapienza
Simone Bini retweeted
Replying to @_SimoneBini_
🌟 The remnant-cholesterol/CRP nexus: Trouble and strife when the fat hits the fire 🌟
Don't miss the 💥 editorial by #DCChan @kritharides and #GFWatts in #ATH!
🔗atherosclerosis-journal.com/…
#CvPrev #CardioTwitter @society_eas
Simone Bini retweeted
Mind the event: SISA sezione lazio
Join and share
@daniele_pastori @FBarattaMD @Arca_Lab_ @_SimoneBini_ @Tramontano_D
Simone Bini retweeted
Ending the first day in Mannheim 🇩🇪 in the best possible way 🤩
#EASCongress2023 and #MyEAS23 is not only a major event of great scientific impact, but also a 360° experience with lots of networking opportunities and exciting insights
Simone Bini retweeted
It’s a new dawn, it’s a new day, it’s a new life! 🌄 Welcome to our new spectral cell sorter #AuroraCS by @CytekBio. Acquired thanks to @SapienzaRoma funding for instrumentation
Simone Bini retweeted
Un evento congiunto imperdibile! @daniele_pastori @Daniele74656753 @_SimoneBini_ @VaBianconi @arturocesaro @lorydad89 @FBarattaMD @FedericaFogacci @Arca_Lab_ @AL_Catapano @afgcicero
Simone Bini retweeted
Just published on Liver International the results of the study on the "Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia". #ItalianWorkingGroupOnLomitapide @kiaretta21 @Arca_Lab_
@_SimoneBini_ @arturocesaro
doi:10.1111/Liv.15497
Simone Bini retweeted
@Arca_Lab_ was designed as training centre in Europe for Familial Chilomicronemia Syndrome. Today we met and greet with collegues from Spain, Portugal and Romania.
Thanks to @Sobi_Italia – at Rome, Lazio


























